NFE2L2 and inflammatory bowel disease: Over the last few decades, the protective role of Nrf2 activation has been established in the treatment of IBD (14, 16), as well as numerous Nrf2 activators have been developed and what's more notable is that some of them are undergoing clinical trials currently (10, 43).